The Triple Agonist Mechanism and Weight Loss Huberman described retatrutide as a triple agonist of the GLP-1, glucagon, and GIP receptors, and noted that it is sometimes referred to as "GLP-3." He made a striking claim about the weight loss data: "In a phase three clinical trial in humans, it caused up to one-third loss of body weight
Importantly, monitoring and regular medical consultations can help manage these side effects effectively
: Body Protection Compound-157, BPC157, -157, BPC 157, BPC-157 , BPC-157 acetate, BPC-157 analog, BPC-157 human, BPC-157 solution BPC-157 BPC-157 : BPC-157 : BPC-157 ,
5 mg Ipamorelin per vial
Glucomannan, psyllium, inulin, beta-glucan, and resistant maltodextrin form viscous gels that slow gastric emptying and blunt postprandial glucose